<DOC>
	<DOCNO>NCT02403999</DOCNO>
	<brief_summary>This single centre , evaluator blind , randomize , parallel group , stratify , two week study healthy participant . The clinical study design provide reassurance formulation develop child baby mild moderately dry skin child whose skin prone atopic dermatitis ( eczema ) well tolerate target population , baby young child dry skin .</brief_summary>
	<brief_title>A Tolerability Assessment Study Three Wash Products Infants</brief_title>
	<detailed_description />
	<criteria>Participants 18 month age screening/baseline visit good general health major physical disability Parent/legal guardian report dry skin Voluntary write informed consent form parent/legal guardian evidence understand study willingness participate Allergy/intolerance hypersensitivity study material state ingredient Participant skin condition warrant medical intervention , current episode eczema/atopic dermatitis episode 3 month prior screen , regular use moisturizers ( variable application frequency ) Use oral corticosteroids/immunosuppressive medication within 4 week topical corticosteroids/topical antiitch product within 2 week baseline Child Care ; participant ' previous participation study/another clinical study/receipt investigational drug within 30 day screen visit Parent/legal guardian age 18 year , employee sponsor study site member immediate family Participant living household already enrol participant</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Months</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>